Navigation Links
MicroAire Surgical Instruments Acquires Endotine® (Formerly Owned by Coapt Systems)
Date:8/19/2010

CHARLOTTESVILLE, Va., Aug. 19 /PRNewswire/ -- MicroAire Surgical Instruments is pleased to announce the acquisition of Endotine® bioabsorbable, multi-point, soft-tissue fixation systems for facial aesthetic surgery. Endotine® is a patented system that allows surgeons to attach soft tissue to bone, or to other soft tissue -- using special tines instead of sutures -- thereby avoiding the tissue-strain associated with sutures.

Although Endotine® devices have the holding power of multiple sutures; the system actually has more in common with hook-and-loop systems, than with traditional needle and thread. This unique system allows surgeons to adjust the degree of lift during surgery. The additional strength from Endotine's® multiple fixation-points reduces tissue stretching and potential suture failure in a variety of facial procedures, including brow lifts, midface lifts, face lifts and neck lifts.

Endotine® is bioabsorbable, which means there are no secondary procedures required for implant removal. Endotine® devices hold tissue securely for three to four months and are then absorbed naturally, typically over a twelve-month period.  With seven years of clinical history, including excellent success rates in peer-reviewed publications, clinical trials showed virtually no issues of inflammation or adverse histologic response.

Customers and distributors of Endotine® devices will see no change in the availability of the products. MicroAire is planning to continue the product, invest in the product and grow the brand.

"Many surgeons already know that this is a fantastic product," said Alan Connor, MicroAire's Vice President of Operations. "We're ensuring that manufacturing and distribution processes remain the same, so that customers and distributors have full access to Endotine® products, as they always have. Same people, same location, same contact information. The only change for now will b
'/>"/>

SOURCE MicroAire Surgical Instruments
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
2. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
3. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
4. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
5. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
6. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
7. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
8. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
9. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
10. Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination
11. New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015 Braeburn ... its current therapeutic focus beyond addiction and ... psychiatric disorders. Braeburn has acquired an implantable, ... antipsychotic risperidone for treatment of schizophrenia from ... acquires global rights to other potential applications ...
(Date:5/1/2015)... -- Pharmacyclics, Inc. (the "Company") (NASDAQ: PCYC ) ... 31, 2015, as well as general business updates. Due ... will be held. Key Highlights , ... increased to $206 million from $119 million for the ... ® (ibrutinib) net product revenue of $247 million ...
(Date:5/1/2015)... May 1, 2015  Misonix, Inc. (NASDAQ: ... designs, manufactures and markets innovative therapeutic ultrasonic products ... cosmetic surgery, laparoscopic surgery and other surgical applications, ... for the third quarter fiscal year 2015 on ... a conference call that same day, Thursday, May ...
Breaking Medicine Technology:Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 5Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 6Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 7Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 8Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 9Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 10Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 12Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 13Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 14Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 15Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 16Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 17Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 18Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 19Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 20Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 21Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 22Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 23Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 24Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 25Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 26Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 27Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 28Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 29Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 30Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 31Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 32Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 33
... Perrigo Company (Nasdaq: PRGO;TASE) today announced that ... approvals necessary to complete the acquisition of Paddock ... of generic Rx pharmaceuticals and OTC specialty products. ... C. Papa stated, "We are looking forward to ...
... Corporation ("Unilife" or the "Company") (NASDAQ: UNIS ... completed the validation phase of the Unifill® ready-to-fill (prefilled) ... in the industrialization process for the Unifill syringe. ... completion of all validation tests associated with the Unifill ...
Cached Medicine Technology:Perrigo Provides Update on Acquisition of Paddock Labs 2Perrigo Provides Update on Acquisition of Paddock Labs 3Unilife Successfully Completes Industrialization of Unifill Syringe 2Unilife Successfully Completes Industrialization of Unifill Syringe 3Unilife Successfully Completes Industrialization of Unifill Syringe 4
(Date:5/2/2015)... May 03, 2015 As one of ... the prestigious Safety and Health Achievement and Recognition Program ... to be chosen by the Illinois Department of Labor ... achieved and maintained SHARP certification by the Occupational Safety ... as Essentra has continued to meet or exceed all ...
(Date:5/2/2015)... May 02, 2015 ProText Kinetic 2 is ... in Final Cut Pro X. ProText Kinetic 2 features ... Final Cut Pro X . Easily create interactive ... Pixel Film Studios' ProText Kinetic 2. , Using ProText Kinetic ... staggering two ProText Kinetic presets in the FCPX timeline. ...
(Date:5/2/2015)... On Tuesday April 7th, the patient ... to celebrate improvements in patient care. In 2014 the ... had zero acquired ventilator associated infections, zero central line ... was also recently named a Top Performer by the ... credited the teamwork of staff from all departments involved ...
(Date:5/2/2015)... With the success that Veatch Dental Consulting has had ... Miranda and Alex Shields to the team. With Neida and ... of combined experience working with dentists to ensure their success. ... 8 years. She was certified as dental assistant from ... attitude and showing the importance of oral hygiene to patients, ...
(Date:5/1/2015)... Jusuru International has been awarded the ... of its flagship nutritional supplement, Liquid BioCell™ Life, and ... name, new logo, new packaging, new products, and new ... to identify and promote programs that serve as examples ... congratulates Jusuru International for their outstanding accomplishments and contributions ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5
... the fact that uncomplicated twin pregnancies may be more ... ,Researchers of Imperial College London report that normal monochorionic ... deaths. In monochorionic diamniotic twin pregnancy, the twin fetuses ... and often are the most common form of twin ...
... that teenage girls living in temperate countries or colder regions ... they took supplements of Vitamin D in the winter months ... sun is important for formation of the active component of ... would help to strengthen bones for later years. The researchers ...
... According to the article published in The Journal of ... of antibiotics for // acute uncomplicated lower respiratory tract ... is a common complaint in the out patient departments ... is treated. ,The randomized controlled trial was ...
... have identified an enzyme’s new role in aiding joint ... called cathepsin G can regulate the ability of the ... process of inflammatory conditions that can lead to arthritis. ... that can lead to damage of the tissue and ...
... reaction to a common water pollutant called arsenic may not ... out to a gene called CYT19 in people, particularly in ... metal called arsenic. ,Arsenic exposure had long been associated ... bladder, circulatory problems, and neurological disorders. It can enter the ...
... vehicles in the world could run using a pollution free ... from Stanford are just working towards this solution to look ... fuel cells and the hydrogen would reacts with oxygen to ... combustion mechanism and this would be pollution free. A similar ...
Cached Medicine News:Health News:Vitamin D Supplement in Teenage Girls essential in Winter months 2Health News:Antibiotics for acute uncomplicated lower respiratory tract infection 2Health News:Pollution Free Hydrogen based fuel for Energy 2Health News:Pollution Free Hydrogen based fuel for Energy 3
Used to negotiate spiral folds of the cystic duct and the lumen of the common duct. TFE coating reduces surface tension. Supplied sterile in peel-open packages. Intended for one-time use....
Used for common bile duct exploration. Supplied sterile in peel-open packages. Intended for one-time use....
... biopsy with the MAMMOTOME® HH ... minimally invasive procedure using ultrasound ... computer-generated images to locate breast ... pinpoint and map the area ...
... temporary wound support. Especially suitable for ... support material is desired and containment ... Predictable absorption. Polyglactin 910 has been ... nonpyrogenic. ,VICRYL (polyglactin 910) knitted mesh ...
Medicine Products: